Original Research
Accepted on 02 Oct 2023
Immune-related adverse events of anti-PD-1 immune checkpoint inhibitors: a single center experience
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 02 Oct 2023
in Cancer Immunity and Immunotherapy
Original Research
Published on 02 Oct 2023
in Cancer Immunity and Immunotherapy
Original Research
Published on 02 Oct 2023
in Cancer Immunity and Immunotherapy
Original Research
Published on 02 Oct 2023
in Cancer Immunity and Immunotherapy
Case Report
Published on 02 Oct 2023
in Cancer Immunity and Immunotherapy
Systematic Review
Published on 29 Sep 2023
in Cancer Immunity and Immunotherapy
Mini Review
Accepted on 28 Sep 2023
in Cancer Immunity and Immunotherapy
Original Research
Published on 28 Sep 2023
in Cancer Immunity and Immunotherapy
Review
Accepted on 27 Sep 2023
in Cancer Immunity and Immunotherapy
Systematic Review
Accepted on 26 Sep 2023
in Cancer Immunity and Immunotherapy
Review
Published on 26 Sep 2023
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 25 Sep 2023
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 25 Sep 2023
in Cancer Immunity and Immunotherapy
Review
Accepted on 22 Sep 2023
in Cancer Immunity and Immunotherapy
Review
Published on 22 Sep 2023
in Cancer Immunity and Immunotherapy
Original Research
Published on 22 Sep 2023
in Cancer Immunity and Immunotherapy